NASHVILLE, Tenn. (AP) -- Vanderbilt-Ingram Cancer Center in Nashville has begun a line of mutation testing for breast cancer patients.
Such patients will now have their breast tumor tissue tested for gene mutations important for treatment decisions.
Information from genetic tests will then be used to match each patient to the best cancer therapies available, including drugs in early clinical trials.
Routine mutation screening already is done for all lung cancer and melanoma patients.
(Copyright 2011 by The Associated Press. All Rights Reserved.)
Viewers with disabilities can get assistance accessing this station's FCC Public Inspection File by contacting the station with the information listed below. Questions or concerns relating to the accessibility of the FCC's online public file system should be directed to the FCC at 888-225-5322, 888-835-5322 (TTY), or firstname.lastname@example.org.